Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/44758
Title: | Determination of serum YKL-40 levels in patients with brucellosis | Other Titles: | Bruselloz hastalarında serum YKL-40 düzeylerinin belirlenmesi | Authors: | Sezgin, Fikriye Milletli Nar, Rukiye |
Abstract: | Aim: To determine serum YKL-40 levels in patients diagnosed with brucellosis.Material and Methods: This study included 40 Brucellosis patients with positive serum agglutination tests and 41 healthy control subjects. The two groups were compared with regard to their serum YKL-40, hematological parameters, and C-reactive protein (CRP) values.Results: The brucellosis patient group presented YKL-40 values of 15.0 ± 8.8 ng/mL, CRP values of 0.2 ± 0.1 mg/dL, a Neutrophil/Lymphocyte ratio (NLR) of 1.5 ± 1.0, and a Platelet/Lymphocyte ratio (PLR) of 109.3 ± 46.4. The control group presented YKL-40 values of 12.7 ± 6.1ng/mL, CRP values of 1.48 ± 2.1mg/dL, a Neutrophil/Lymphocyte ratio (NLR) of 2.1 ± 0.7, and a Platelet/Lymphocyte ratio (PLR) of 147.8 ± 59.0.Conclusion: No significant differences were determined between the YKL-40 levels of the patient and control groups. The patient group manifested significantly higher levels of CRP compared to the control group, and YKL-40 was determined to be positively correlated with CRP, PLT, PLR, NLR and age. However, further studies are needed for the role of YKL-40 in infectious diseases to be understood more clearly. | URI: | https://hdl.handle.net/11499/44758 https://doi.org/10.18663/tjcl.472868 |
ISSN: | 2149-8296 2149-8296 |
Appears in Collections: | Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Determination of serum YKL.pdf | 8.81 MB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
44
checked on Aug 24, 2024
Download(s)
16
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.